Aerobiotix partners with Battelle to perform SARS-CoV-2 bioaerosol elimination testing
Aerobiotix has partnered with Battelle to perform SARS-CoV-2 bioaerosol elimination testing of our photolytic filtration technology. This critical work will utilize Battelle’s biosafety facility in Columbus, Ohio using custom-designed aerosolization and sampling chambers. The project is groundbreaking: No environmental air decontamination device, to our knowledge, has been validated against live aerosolized SARS-Cov-2. This major investment in sound science exemplifies the global leadership of Aerobiotix in improving healthcare safety for patients and clinicians.